Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

HIV PrEP Patent Dispute Escalates As HHS Files Suit Against Gilead

Nov 08 2019

• By Mandy Jackson

SC1911_Patent Infringement_417199606_1200.jpg — HHS wants Gilead to license patents based on government-funded PrEP research. • Source: Shutterstock

Related Content

Gilead’s Descovy Nabs Limited HIV Prophylaxis Indication Pending A New Study In Women

Oct 04 2019

End Of The 'March-In' Pricing Petitions?

Apr 25 2019

NIH Reluctant To “March In”: Collins Suggests Authority Not Intended To Address Pricing Concerns

Apr 20 2016

Related Companies

Gilead Sciences, Inc.

Teva Pharmaceutical Industries Ltd.

Additional Topics

Intellectual Property Legal Issues Policy Infectious Diseases BioPharmaceutical

More from Legal & IP

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window